S. Salvin - Concepedia

Author

S. Salvin

University of Udine

Also Known As

S Salvin, S. Salvin, Sara Salvin

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Udine Ospedale Santa Maria della Misericordia di Udine University of Pisa Centro di Riferimento Oncologico Luigi Sacco Hospital

About

S. Salvin is an author at University of Udine specializing in sjögren’s syndrome, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	189
2	Immunology	2	2	189
3	Pathology	2	2	189
4	Autoimmune Disease	2	2	189
5	Rheumatology	1	1	38

S. Salvin

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study Xavier Mariette, Raphaèle Séror, Luca Quartuccio, Annals of the Rheumatic Diseases	2013	308
Biomarkers of lymphoma in Sjögren’s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study Luca Quartuccio, Miriam Isola, Chiara Baldini, Journal of Autoimmunity Lymphoid NeoplasiaAutoimmune DiseaseSjögren’s SyndromeMedicineHematology	2013	151
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands Luca Quartuccio, S. Salvin, Martina Fabris, Lara D. Veeken	2012	140
Efficacy and safety of belimumab given for 12 months in primary Sjögren’s syndrome: the BELISS open-label phase II study Salvatore De Vita, Luca Quartuccio, Raphaèle Séror, Lara D. Veeken	2015	140
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands. Alen Zabotti, S. Salvin, Luca Quartuccio, PubMed	2016	94
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis Luca Quartuccio, Martina Fabris, S. Salvin, Lara D. Veeken	2009	93
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. Salvatore De Vita, Luca Quartuccio, S. Salvin, PubMed	2014	85
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study Luca Quartuccio, Martina Fabris, Elena Pontarini, Annals of the Rheumatic Diseases	2013	69
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study Luca Quartuccio, Miriam Isola, Chiara Baldini, Scandinavian Journal of Rheumatology	2014	58
Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation Luca Quartuccio, Martina Fabris, S. Salvin, International Journal of Rheumatology ImmunologyPathologyImmunotherapyRheumatoid DisorderChimeric Monoclonal Antibody	2009	38

Page 1